Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma

[1]  A. Woodcock,et al.  Fluticasone furoate demonstrates efficacy in patients with asthma symptomatic on medium doses of inhaled corticosteroid therapy: an 8-week, randomised, placebo-controlled trial , 2011, Thorax.

[2]  D. Postma,et al.  Prolonged protection of the new inhaled corticosteroid fluticasone furoate against AMP hyperresponsiveness in patients with asthma , 2010, Allergy.

[3]  W. Lincourt,et al.  Predictors of Uncontrolled Asthma in Adult and Pediatric Patients: Analysis of the Asthma Control Characteristics and Prevalence Survey Studies (ACCESS) , 2010, The Journal of asthma : official journal of the Association for the Care of Asthma.

[4]  D. Price,et al.  Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study , 2010, BMC pulmonary medicine.

[5]  E. Bleecker,et al.  Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study. , 2009, The Journal of allergy and clinical immunology.

[6]  W. Lincourt,et al.  Assessment of asthma control in primary care , 2009, Current medical research and opinion.

[7]  C. Rand,et al.  Modifiable Risk Factors for Suboptimal Control and Controller Medication Underuse Among Children With Asthma , 2009, Pediatrics.

[8]  I. McLay,et al.  X-ray crystal structure of the novel enhanced-affinity glucocorticoid agonist fluticasone furoate in the glucocorticoid receptor-ligand binding domain. , 2008, Journal of medicinal chemistry.

[9]  S. Farrow,et al.  Pharmacological properties of the enhanced-affinity glucocorticoid fluticasone furoate in vitro and in an in vivo model of respiratory inflammatory disease. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[10]  M. Weatherall,et al.  Fluticasone given once versus twice a day: Meta‐analysis , 2005, Respirology.

[11]  Christine C Johnson,et al.  Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. , 2004, The Journal of allergy and clinical immunology.

[12]  Kevin B Weiss,et al.  Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. , 2004, The Journal of allergy and clinical immunology.

[13]  R. Stanford,et al.  Treatment patterns in the months prior to and after asthma-related emergency department visit. , 2004, Chest.

[14]  Jennifer Cleland,et al.  The Living & Breathing Study: a study of patients' views of asthma and its treatment. , 2004, Primary care respiratory journal : journal of the General Practice Airways Group.

[15]  A. Tattersfield,et al.  Time course of action of two inhaled corticosteroids, fluticasone propionate and budesonide , 2003, Thorax.

[16]  M. Purucker,et al.  Inhaled fluticasone propionate by diskus in the treatment of asthma: a comparison of the efficacy of the same nominal dose given either once or twice a day. , 2003, Chest.

[17]  R. Pauwels,et al.  Low-dose inhaled corticosteroids and the prevention of death from asthma. , 2000, The New England journal of medicine.

[18]  G. Crompton,et al.  Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. , 2001, The European respiratory journal.

[19]  D. Postma,et al.  Treatment of asthma by the inhaled corticosteroid ciclesonide given either in the morning or evening. , 2001, The European respiratory journal.

[20]  R. Martin,et al.  Further studies on the chronotherapy of asthma with inhaled steroids: the effect of dosage timing on drug efficacy. , 1997, The Journal of allergy and clinical immunology.

[21]  Third Expert Panel on theDiagnosis,et al.  Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma , 1997 .

[22]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[23]  C. G. Langdon,et al.  Pulmicort Turbohaler once daily as initial prophylactic therapy for asthma. , 1994, Respiratory medicine.

[24]  D. Webb,et al.  Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler. , 2001, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.